{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:36:57Z","timestamp":1791927417047,"version":"4.3.4"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"22","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,29]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Systemic inflammation, metabolic dysregulation, and thrombotic activity may all contribute to disease progression and prognosis in nonalcoholic fatty liver disease (NAFLD). However, the relative prognostic performance of biomarkers reflecting these pathways remains unclear. This study aimed to compare 3 biologically distinct indices \u2013 neutrophil-to-lymphocyte ratio (NLR), neutrophil-to-HDL cholesterol ratio (NHR), and platelet-to-lymphocyte ratio (PLR) \u2013 and to investigate the association between the optimal marker and the risk of all-cause and cardiovascular mortality among American adults with NAFLD. This study included 5830 adults with NAFLD from the National Health and Nutrition Examination Survey (1999\u20132018). Time-dependent receiver operating characteristic (ROC) analyses were performed to compare the discriminative performance of NLR, NHR, and PLR at multiple follow-up time points. Based on comparative results, NLR was selected for subsequent analyses. Cox proportional hazards regression models were used to elucidate the relationship between NLR levels and mortality in NAFLD patients, and stratified analyses were performed to identify patients with higher mortality risk. Restricted cubic spline, Kaplan\u2013Meier curves, Time-dependent receiver operating characteristic curve (ROC) analysis, and sensitivity analyses were also conducted to visualize the association of the NLR with mortality risk. During a median follow-up of 110 months, 1087 all-cause deaths occurred. In time-dependent ROC analysis, NLR consistently demonstrated superior discriminative performance compared with NHR and PLR across all evaluated time points. After adjusting for covariates, compared to participants with lower NLR (\u22642.88) levels, those with higher NLR (&gt;2.88) levels had a 56% increased risk for all-cause mortality (hazard ratio 1.56, 95% confidence interval: 1.29\u20131.89,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.0001) and 89% higher risk for cardiovascular disease (CVD) mortality (hazard ratio 1.89, 95% confidence interval: 1.39\u20132.58,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.0001). The results were robust in subgroup and sensitivity analyses. Kaplan\u2013Meier analysis showed that the survival was significantly worse in the high NLRs group than in the low NLRs group for both total and CVD (both\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.0001). Furthermore, the Restricted cubic spline curve showed a positive linear and reverse L-shaped relationship between NLR and overall mortality and cardiovascular mortality, respectively. This research suggests that NLR is independently associated with all-cause and CVD mortality, and NLR\u2005&gt;\u20052.88 may be a risk factor for mortality.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048962","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:07:21Z","timestamp":1780074441000},"page":"e48962","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["The neutrophil-to-lymphocyte ratio predicts all-cause and cardiovascular mortality in patients with nonalcoholic fatty liver disease: Evidence from the National Health and Nutrition Examination Survey 1999 to 2018"],"prefix":"10.1097","volume":"105","author":[{"given":"Zhihang","family":"Du","sequence":"first","affiliation":[{"name":"The Department of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Jiang","sequence":"additional","affiliation":[{"name":"The Department of Infectious Diseases, The Affiliated Hospital of Qingdao University, Qingdao, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyu","family":"Lv","sequence":"additional","affiliation":[{"name":"The Department of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hou","sequence":"additional","affiliation":[{"name":"The Department of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3365-1319","authenticated-orcid":false,"given":"Dan","family":"Li","sequence":"additional","affiliation":[{"name":"The Department of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260827","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11883-022-01028-4","article-title":"Management of dyslipidemia in patients with non-alcoholic fatty liver disease.","volume":"24","author":"Martin","year":"2022","journal-title":"Curr Atheroscler Rep"},{"key":"R2-20260827","doi-asserted-by":"crossref","first-page":"773342","DOI":"10.3389\/fendo.2021.773342","article-title":"Association between diabetes mellitus and all-cause and cardiovascular mortality among individuals with ultrasound-defined non-alcoholic fatty liver disease.","volume":"12","author":"Wu","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R3-20260827","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1002\/hep4.2081","article-title":"Outcomes of subjects who are lean, overweight or obese with nonalcoholic fatty liver disease: a cohort study in China.","volume":"6","author":"Lan","year":"2022","journal-title":"Hepatol Commun"},{"key":"R4-20260827","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement.","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"R5-20260827","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/liv.13994","article-title":"Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes: a meta-analysis with bias analysis.","volume":"39","author":"Morrison","year":"2019","journal-title":"Liver Int"},{"key":"R6-20260827","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.3390\/ijms20092215","article-title":"Cardio-metabolic disorders in non-alcoholic fatty liver disease.","volume":"20","author":"El Hadi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R7-20260827","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis.","volume":"22","author":"Huby","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"R8-20260827","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jhep.2023.02.033","article-title":"Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation.","volume":"79","author":"Yahoo","year":"2023","journal-title":"J Hepatol"},{"key":"R9-20260827","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease.","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"R10-20260827","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41591-019-0379-5","article-title":"Platelet GPIb\u03b1 is a mediator and potential interventional target for NASH and subsequent liver cancer.","volume":"25","author":"Malehmir","year":"2019","journal-title":"Nat Med"},{"key":"R11-20260827","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/hep.28526","article-title":"Platelets: no longer bystanders in liver disease.","volume":"64","author":"Chauhan","year":"2016","journal-title":"Hepatology"},{"key":"R12-20260827","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/STROKEAHA.120.032130","article-title":"Neutrophil-to-lymphocyte ratio predicts cerebral edema and clinical worsening early after reperfusion therapy in stroke.","volume":"52","author":"Ferro","year":"2021","journal-title":"Stroke"},{"key":"R13-20260827","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1161\/STROKEAHA.118.021477","article-title":"Admission neutrophil-to-lymphocyte ratio as a prognostic biomarker of outcomes in large vessel occlusion strokes.","volume":"49","author":"Goyal","year":"2018","journal-title":"Stroke"},{"key":"R14-20260827","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/s41440-019-0245-3","article-title":"Neutrophil to lymphocyte ratio as predictor for incident hypertension: a 9-year cohort study in Taiwan.","volume":"42","author":"Jhuang","year":"2019","journal-title":"Hypertens Res"},{"key":"R15-20260827","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s12916-020-01817-1","article-title":"Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies.","volume":"18","author":"Cupp","year":"2020","journal-title":"BMC Med"},{"key":"R16-20260827","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.atherosclerosis.2017.08.007","article-title":"Pre-procedural neutrophil-to-lymphocyte ratio and long-term cardiac outcomes after percutaneous coronary intervention for stable coronary artery disease.","volume":"265","author":"Wada","year":"2017","journal-title":"Atherosclerosis"},{"key":"R17-20260827","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/DMSO.S330526","article-title":"Diagnostic value of neutrophil to lymphocyte ratio in non-alcoholic fatty liver disease evaluated using transient elastography (TE) with controlled attenuated parameter (CAP).","volume":"15","author":"Lesmana","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R18-20260827","doi-asserted-by":"crossref","first-page":"1554079","DOI":"10.1155\/2022\/1554079","article-title":"Prognostic role of neutrophil to lymphocyte ratio in nonalcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"2022","author":"Shavakhi","year":"2022","journal-title":"Can J Gastroenterol Hepatol"},{"key":"R19-20260827","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.3390\/nu15081892","article-title":"Predictive role of neutrophil-percentage-to-albumin ratio (NPAR) in nonalcoholic fatty liver disease and advanced liver fibrosis in nondiabetic US adults: evidence from NHANES 2017-2018.","volume":"15","author":"Liu","year":"2023","journal-title":"Nutrients"},{"key":"R20-20260827","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12933-023-01998-y","article-title":"The neutrophil-lymphocyte ratio as a risk factor for all-cause and cardiovascular mortality among individuals with diabetes: evidence from the NHANES 2003-2016.","volume":"22","author":"Dong","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"R21-20260827","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/apt.13012","article-title":"Fatty liver indices in the multiethnic United States national health and nutrition examination survey.","volume":"41","author":"Ruhl","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"R22-20260827","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3350\/cmh.2022.0096","article-title":"The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease.","volume":"28","author":"Ng","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"R23-20260827","doi-asserted-by":"crossref","first-page":"E91","DOI":"10.1097\/HEP.0000000000000695","article-title":"Letter to the editor: a multi-society Delphi consensus statement on new fatty liver disease nomenclature.","volume":"79","author":"Hoofnagle","year":"2024","journal-title":"Hepatology"},{"key":"R24-20260827","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/hep4.1803","article-title":"Inverse association of telomere length with liver disease and mortality in the US population.","volume":"6","author":"Rattan","year":"2022","journal-title":"Hepatol Commun"},{"key":"R25-20260827","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/CM9.0000000000002753","article-title":"Hypertension and NAFLD risk: insights from the NHANES 2017-2018 and Mendelian randomization analyses.","volume":"137","author":"Yuan","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"R26-20260827","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12916-023-03005-3","article-title":"Racial differences in long-term social, physical, and psychological health among adolescent and young adult cancer survivors.","volume":"21","author":"Kim","year":"2023","journal-title":"BMC Med"},{"key":"R27-20260827","doi-asserted-by":"crossref","first-page":"e2326230","DOI":"10.1001\/jamanetworkopen.2023.26230","article-title":"Estimated prevalence and testing for albuminuria in US adults at risk for chronic kidney disease.","volume":"6","author":"Chu","year":"2023","journal-title":"JAMA Netw Open"},{"key":"R28-20260827","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/jcsm.13397","article-title":"Association of low muscle mass and obesity with increased all-cause and cardiovascular disease mortality in US adults.","volume":"15","author":"Kim","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R29-20260827","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.jhep.2023.10.032","article-title":"MASLD screening and diagnostic algorithms are interchangeable with existing NAFLD literature.","volume":"80","author":"Arora","year":"2024","journal-title":"J Hepatol"},{"key":"R30-20260827","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1016\/j.jhep.2023.08.021","article-title":"Clinical and histological features under different nomenclatures of fatty liver disease: NAFLD, MAFLD, MASLD and MetALD.","volume":"80","author":"Chen","year":"2024","journal-title":"J Hepatol"},{"key":"R31-20260827","doi-asserted-by":"crossref","first-page":"11629","DOI":"10.3390\/ijms222111629","article-title":"Pathophysiological molecular mechanisms of obesity: a link between MAFLD and NASH with cardiovascular diseases.","volume":"22","author":"Guti\u00e9rrez-Cuevas","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R32-20260827","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12933-022-01697-0","article-title":"Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention.","volume":"21","author":"Zhou","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"R33-20260827","doi-asserted-by":"crossref","first-page":"100524","DOI":"10.1016\/j.jhepr.2022.100524","article-title":"Understanding the cellular interactome of non-alcoholic fatty liver disease.","volume":"4","author":"Wallace","year":"2022","journal-title":"JHEP Rep"},{"key":"R34-20260827","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-pathmechdis-012418-013003","article-title":"Innate immune signaling in nonalcoholic fatty liver disease and cardiovascular diseases.","volume":"14","author":"Cai","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"R35-20260827","doi-asserted-by":"crossref","first-page":"6889733","DOI":"10.1155\/2021\/6889733","article-title":"The predictive role of neutrophil-to-lymphocyte ratio (NLR) and mean platelet volume-to-lymphocyte ratio (MPVLR) for cardiovascular events in adult patients with acute heart failure.","volume":"2021","author":"Angkananard","year":"2021","journal-title":"Mediators Inflamm"},{"key":"R36-20260827","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cca.2018.06.021","article-title":"Prognostic value of neutrophil to lymphocyte ratio in heart failure patients.","volume":"485","author":"Wang","year":"2018","journal-title":"Clin Chim Acta"},{"key":"R37-20260827","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s12872-023-03316-6","article-title":"Association between neutrophil percentage-to-albumin ratio (NPAR), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and long-term mortality in community-dwelling adults with heart failure: evidence from US NHANES 2005-2016.","volume":"23","author":"Wu","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"R38-20260827","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.atherosclerosis.2014.03.003","article-title":"Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis of observational studies.","volume":"234","author":"Wang","year":"2014","journal-title":"Atherosclerosis"},{"key":"R39-20260827","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/eurheartj\/ehaa1034","article-title":"The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials.","volume":"42","author":"Adamstein","year":"2021","journal-title":"Eur Heart J"},{"key":"R40-20260827","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10654-018-0472-y","article-title":"The neutrophil-to-lymphocyte ratio is associated with mortality in the general population: the Rotterdam Study.","volume":"34","author":"Fest","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"R41-20260827","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41598-020-79431-7","article-title":"Neutrophil-to-lymphocyte ratio and mortality in the United States general population.","volume":"11","author":"Song","year":"2021","journal-title":"Sci Rep"},{"key":"R42-20260827","doi-asserted-by":"crossref","first-page":"22362","DOI":"10.1038\/s41598-023-49403-8","article-title":"Comparative analysis of neutrophil-to-lymphocyteratio and remnant cholesterol in predicting cardiovascular events and mortality in general adult population.","volume":"13","author":"Wang","year":"2023","journal-title":"Sci Rep"},{"key":"R43-20260827","doi-asserted-by":"crossref","first-page":"847998","DOI":"10.3389\/fcvm.2022.847998","article-title":"The core role of neutrophil-lymphocyte ratio to predict all-cause and cardiovascular mortality: a research of the 2005-2014 national health and nutrition examination survey.","volume":"9","author":"Gu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"R44-20260827","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature.","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"R45-20260827","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1016\/j.jhep.2023.08.025","article-title":"Changing from NAFLD through MAFLD to MASLD: similar prevalence and risk factors in a large Brazilian cohort.","volume":"80","author":"Perazzo","year":"2024","journal-title":"J Hepatol"},{"key":"R46-20260827","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/j.jhep.2023.07.021","article-title":"Can we use old NAFLD data under the new MASLD definition?","volume":"80","author":"Song","year":"2024","journal-title":"J Hepatol"},{"key":"R47-20260827","doi-asserted-by":"crossref","first-page":"154911","DOI":"10.1016\/j.metabol.2021.154911","article-title":"Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study.","volume":"126","author":"Tan","year":"2022","journal-title":"Metabolism"},{"key":"R48-20260827","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R49-20260827","doi-asserted-by":"crossref","first-page":"101643","DOI":"10.1016\/j.cpcardiol.2023.101643","article-title":"Cardiovascular morbidity and mortality related to non-alcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"48","author":"Bisaccia","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"R50-20260827","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.cgh.2022.11.019","article-title":"Mortality and liver-related events in lean versus non-lean nonalcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"21","author":"Ha","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R51-20260827","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00535-024-02093-z","article-title":"Natural history of lean and non-lean metabolic dysfunction-associated steatotic liver disease.","volume":"59","author":"Wakabayashi","year":"2024","journal-title":"J Gastroenterol"},{"key":"R52-20260827","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1039\/D3FO00242J","article-title":"Dietary flavonoid intake is associated with a lower risk of diabetic nephropathy in US adults: data from NHANES 2007-2008, 2009-2010, and 2017-2018.","volume":"14","author":"Liu","year":"2023","journal-title":"Food Funct"},{"key":"R53-20260827","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/liv.15078","article-title":"Association of genetic variations with NAFLD in lean individuals.","volume":"42","author":"Lin","year":"2022","journal-title":"Liver Int"},{"key":"R54-20260827","first-page":"71","article-title":"Diversity in NAFLD: a review of manifestations of nonalcoholic fatty liver disease in different ethnicities globally.","volume":"9","author":"Han","year":"2021","journal-title":"J Clin Transl Hepatol"},{"key":"R55-20260827","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/ajg.2011.400","article-title":"Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults.","volume":"107","author":"Sinn","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"R56-20260827","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12979-023-00370-8","article-title":"Temporal trends, sex differences, and age-related disease influence in neutrophil, lymphocyte count and neutrophil to lymphocyte-ratio: results from InCHIANTI follow-up study.","volume":"20","author":"Pellegrino","year":"2023","journal-title":"Immun Ageing"},{"key":"R57-20260827","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.eprac.2021.11.083","article-title":"Is the neutrophil-to-lymphocyte ratio an exceptional indicator for metabolic syndrome disease and outcomes?","volume":"28","author":"Hashemi Moghanjoughi","year":"2022","journal-title":"Endocr Pract"},{"key":"R58-20260827","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1089\/dia.2013.0264","article-title":"Association of neutrophil-lymphocyte ratio with glucose intolerance: an indicator of systemic inflammation in patients with type 2 diabetes.","volume":"16","author":"Shiny","year":"2014","journal-title":"Diabetes Technol Ther"},{"key":"R59-20260827","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American heart association.","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R60-20260827","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/gutjnl-2023-331003","article-title":"Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease.","volume":"73","author":"Lee","year":"2024","journal-title":"Gut"},{"key":"R61-20260827","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1093\/cvr\/cvab302","article-title":"Neutrophils in cardiovascular disease: warmongers, peacemakers, or both?","volume":"118","author":"Sreejit","year":"2022","journal-title":"Cardiovasc Res"},{"key":"R62-20260827","doi-asserted-by":"crossref","first-page":"105912","DOI":"10.1016\/j.phrs.2021.105912","article-title":"Management of inflammation in cardiovascular diseases.","volume":"173","author":"Goswami","year":"2021","journal-title":"Pharmacol Res"},{"key":"R63-20260827","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/CIRCRESAHA.123.321750","article-title":"NETs-induced thrombosis impacts on cardiovascular and chronic kidney disease.","volume":"132","author":"Thakur","year":"2023","journal-title":"Circ Res"},{"key":"R64-20260827","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1161\/CIRCRESAHA.120.315931","article-title":"Neutrophil extracellular traps participate in cardiovascular diseases: recent experimental and clinical insights.","volume":"126","author":"D\u00f6ring","year":"2020","journal-title":"Circ Res"},{"key":"R65-20260827","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1093\/eurheartj\/ehl222","article-title":"Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes.","volume":"27","author":"Mor","year":"2006","journal-title":"Eur Heart J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048962","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:01:15Z","timestamp":1787828475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":65,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048962","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"2025-10-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}